Novel coronavirus COVID-19 mRNA vaccine vials. Illustrative image not the actual product

RFID:2DFN7BC

Preview

Buy the print

Image details

Contributor:

Manjurul Haque / Alamy Stock Photo

Image ID:

2DFN7BC

File size:

100.1 MB (1.7 MB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

7240 x 4833 px | 61.3 x 40.9 cm | 24.1 x 16.1 inches | 300dpi

Date taken:

5 December 2020

Search stock photos by tags

Similar stock images

RF2DFN7D6–Novel coronavirus COVID-19 mRNA vaccine vials. Illustrative image not the actual product

RF2RYFCPJ–Medical NHS worker holding COVID-19 SARS-CoV-2 vaccine glass ampoule vial,wearing personal protectiv

RF2DFCW1B–Moderna in the race to deliver the Covid-19 vaccine

RM2E0C5EC–Jerusalem, Israel. 31st Dec, 2020. Nurses administer COVID-19 vaccines to elderly people 60 and over at the Pais Arena Sports Complex in Jerusalem, converted into a Coronavirus vaccination center. The number of Israeli citizens who have received the first of two doses of the Pfizer BioNTech vaccine is expected to reach 1M by the end of the day as a mass vaccination campaign continues, as does COVID-19 infection in the general public. Credit: Nir Alon/Alamy Live News

RM2KC5WFP–Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amste

RM2EDPDYE–laptop with the word mRNA-1273 on the screen, codename of the Covid-19 vaccine of Moderna

RF2HC2W80–Medical NHS worker holding COVID-19 SARS-CoV-2 vaccine glass ampoule vial,wearing personal protective gear,white clean suit,blue gloves,Coronavirus cu

RM2E1K478–The Novel Coronavirus inactivated vaccine production line keeps busy on making COVID-19 vaccine in Beijing, China on January 6, 2021. (Photo by Top Photo/Sipa USA)

RM2B7R778–March 17, 2020, Moderna Therapeutics, Cambridge, Massachusetts, USA: Exterior of Moderna Therapeutics in Cambridge, Massachusetts USA. Moderna Therapeutics announced that it has dosed the first patient in a phase I study, evaluating its mRNA-based vaccine candidate, mRNA-1273, against the novel coronavirus (SARS-CoV-2).

RM2EDPBD6–woman's hand with stamp lettering mRNA-1273, vaccine of company Moderna, Germany

RM2F2YW02–Moderna announced Wednesday that it has administered the first doses of a modified vaccine designed to fight coronavirus variants to study participants. The company said it is observing the efficacy of two different modified vaccines in a small study involving 60 people who already received the original vaccine. The Cambridge, Mass., company, which has one of the Covid-19 vaccines widely in use, plans to enroll 60 people to test the new shot. The subjects had previously received the standard two doses of Moderna’s original shot as part of a mid-stage study that began last year.

RF2DFN7BG–Novel coronavirus COVID-19 mRNA vaccine vials. Illustrative image not the actual product

RF2DFCWAX–Moderna in the race to deliver the Covid-19 vaccine

Novel coronavirus COVID-19 mRNA vaccine vials. Illustrative image not the actual product

Image details

Search stock photos by tags

Get great features with your free account

Get inspired for your next project!